The goal of the study is to conduct a pilot test of the psychosocial support intervention with family caregivers and/or patients coping with glioblastoma.
The specific aims of this study is to pilot test the psychosocial support program for patients with glioblastoma and/or their family caregivers. The investigators will recruit patient-caregiver dyads for the psychosocial support intervention; participants will have the choice whether to take part in the intervention as a dyad or individually given the variability of symptoms and progression of glioblastoma. The investigators will examine acceptability and feasibility of the intervention and examine whether participation in the program can help reduce distress and improve quality of life.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
11
Participants will receive six weekly 60-minute sessions conducted by videoconference.
Duke University Medical Center
Durham, North Carolina, United States
Number of participants who complete study participation
Completion of sessions by 70% of participants across a four-month period
Time frame: End of study (4-months)
Number of participants who complete post-intervention assessment
Completion of assessments by 70% of participants across a four-month period
Time frame: End of study (4-months)
Participants' satisfaction with treatment
Overall satisfaction rating for the psychosocial intervention with 70% of patients and caregivers reporting satisfaction. The Evaluation of Services measure will take the average of the item scores (0-4), with a mean of 3.0/4.0 as an indication of satisfaction
Time frame: End of study (4-months)
Anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS)
The HADS will measure symptoms of anxiety and depression. The measure has 14 items (higher scores indicate higher distress).
Time frame: Baseline; Post-intervention follow up (up to 4 months)
General distress as measured by the Distress Thermometer
The Distress Thermometer will be used to measure general distress (higher scores indicate higher distress).
Time frame: Baseline; Post-intervention follow up (up to 4 months)
Functional well-being as measured by the Functional Assessment of Cancer Therapy - General (FACT-G)
The functional well-being subscale of the FACT-G will be used to measure functional well-being (higher scores indicate higher functional well-being).
Time frame: Baseline; Post-intervention follow up (up to 4 months)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Caregiving efficacy as measured by the caregiver inventory
The caregiver inventory will be used to measure caregiving efficacy. The measure has 21 items (higher scores indicate higher levels of efficacy).
Time frame: Baseline; Post-intervention follow up (up to 4 months)